fda compounding semaglutide warning 2025 october New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our September 15, 2025: Telehealth company

Quality matters enormously with compounded peptides

Not because these are superior foods, but because they are gentle on a slow-moving gut

We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth

71% of U.S

CVOs include the pineal gland, the organum vasculosum of the lamina terminalis (OVLTs), the subfornical organ (SFO), the choroid plexus, the region postrema (AP), the pituitary glands posterior lobe, the subcommissural organ, and the median eminence (ME) of the mediobasal hypothalamus

Of note, the overall incidence of small bowel obstruction was low (1.4%), and no case was reported in the semaglutide group